What's new

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised

Feb 18, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Avamys, fluticasone fu...

Next Article

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel...

Related Posts

EMA human resources strategy: Priorities 2023-2025

Feb 9, 2025  0

Non-clinical Working Party

Non-clinical Working Party

Feb 9, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric maltol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0503/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 19, 2025  0